Primary biliary cirrhosis: What we know and what we want to know about human PBC and spontaneous PBC mouse models

Yoshiyuki Ueno, Yuki Moritoki, Tooru Shimosegawa, M. Eric Gershwin

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Human autoimmune cholangiopathy comprises several intractable liver diseases that ultimately lead to hepatic failure. Primary biliary cirrhosis (PBC), allograft rejection, graft versus host diseases, and, possibly, primary sclerosing cholangitis are representative of immune-mediated cholangiopathies. Among them, PBC is the best-investigated human autoimmune cholangiopathy. The immunological approach to PBC has provided much critical information regarding its pathogenesis. The breakdown of self-tolerance in both B cells and T cells toward E2 components of the pyruvate dehydrogenase complex is evident. However, a number of questions regarding its etiology are unclear, in particular, the mechanisms involved in the selectivity of cholangiocyte destruction. In this brief review, we discuss what we know and we do not know regarding the pathogenesis of PBC.

Original languageEnglish (US)
Pages (from-to)189-195
Number of pages7
JournalJournal of Gastroenterology
Volume42
Issue number3
DOIs
StatePublished - Mar 2007

Fingerprint

Biliary Liver Cirrhosis
Dihydrolipoyllysine-Residue Acetyltransferase
Self Tolerance
Sclerosing Cholangitis
Liver Failure
Graft vs Host Disease
Allografts
Liver Diseases
B-Lymphocytes
T-Lymphocytes

Keywords

  • Animal model
  • Autoimmunity
  • Cholangiocyte
  • Cholestaticliver disease
  • Heterogeneity

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Primary biliary cirrhosis : What we know and what we want to know about human PBC and spontaneous PBC mouse models. / Ueno, Yoshiyuki; Moritoki, Yuki; Shimosegawa, Tooru; Gershwin, M. Eric.

In: Journal of Gastroenterology, Vol. 42, No. 3, 03.2007, p. 189-195.

Research output: Contribution to journalArticle

@article{a2bb5d129b7a4d46aee031fe98e1ee54,
title = "Primary biliary cirrhosis: What we know and what we want to know about human PBC and spontaneous PBC mouse models",
abstract = "Human autoimmune cholangiopathy comprises several intractable liver diseases that ultimately lead to hepatic failure. Primary biliary cirrhosis (PBC), allograft rejection, graft versus host diseases, and, possibly, primary sclerosing cholangitis are representative of immune-mediated cholangiopathies. Among them, PBC is the best-investigated human autoimmune cholangiopathy. The immunological approach to PBC has provided much critical information regarding its pathogenesis. The breakdown of self-tolerance in both B cells and T cells toward E2 components of the pyruvate dehydrogenase complex is evident. However, a number of questions regarding its etiology are unclear, in particular, the mechanisms involved in the selectivity of cholangiocyte destruction. In this brief review, we discuss what we know and we do not know regarding the pathogenesis of PBC.",
keywords = "Animal model, Autoimmunity, Cholangiocyte, Cholestaticliver disease, Heterogeneity",
author = "Yoshiyuki Ueno and Yuki Moritoki and Tooru Shimosegawa and Gershwin, {M. Eric}",
year = "2007",
month = "3",
doi = "10.1007/s00535-007-2019-y",
language = "English (US)",
volume = "42",
pages = "189--195",
journal = "Journal of Gastroenterology",
issn = "0944-1174",
publisher = "Springer Japan",
number = "3",

}

TY - JOUR

T1 - Primary biliary cirrhosis

T2 - What we know and what we want to know about human PBC and spontaneous PBC mouse models

AU - Ueno, Yoshiyuki

AU - Moritoki, Yuki

AU - Shimosegawa, Tooru

AU - Gershwin, M. Eric

PY - 2007/3

Y1 - 2007/3

N2 - Human autoimmune cholangiopathy comprises several intractable liver diseases that ultimately lead to hepatic failure. Primary biliary cirrhosis (PBC), allograft rejection, graft versus host diseases, and, possibly, primary sclerosing cholangitis are representative of immune-mediated cholangiopathies. Among them, PBC is the best-investigated human autoimmune cholangiopathy. The immunological approach to PBC has provided much critical information regarding its pathogenesis. The breakdown of self-tolerance in both B cells and T cells toward E2 components of the pyruvate dehydrogenase complex is evident. However, a number of questions regarding its etiology are unclear, in particular, the mechanisms involved in the selectivity of cholangiocyte destruction. In this brief review, we discuss what we know and we do not know regarding the pathogenesis of PBC.

AB - Human autoimmune cholangiopathy comprises several intractable liver diseases that ultimately lead to hepatic failure. Primary biliary cirrhosis (PBC), allograft rejection, graft versus host diseases, and, possibly, primary sclerosing cholangitis are representative of immune-mediated cholangiopathies. Among them, PBC is the best-investigated human autoimmune cholangiopathy. The immunological approach to PBC has provided much critical information regarding its pathogenesis. The breakdown of self-tolerance in both B cells and T cells toward E2 components of the pyruvate dehydrogenase complex is evident. However, a number of questions regarding its etiology are unclear, in particular, the mechanisms involved in the selectivity of cholangiocyte destruction. In this brief review, we discuss what we know and we do not know regarding the pathogenesis of PBC.

KW - Animal model

KW - Autoimmunity

KW - Cholangiocyte

KW - Cholestaticliver disease

KW - Heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=33947703541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947703541&partnerID=8YFLogxK

U2 - 10.1007/s00535-007-2019-y

DO - 10.1007/s00535-007-2019-y

M3 - Article

C2 - 17380276

AN - SCOPUS:33947703541

VL - 42

SP - 189

EP - 195

JO - Journal of Gastroenterology

JF - Journal of Gastroenterology

SN - 0944-1174

IS - 3

ER -